SyndromeConstrictionConstriction, PathologicVasoconstrictionDown SyndromeMetabolic Syndrome XArteriolesNephrotic SyndromeSjogren's SyndromeTurner SyndromeDuctus ArteriosusAbnormalities, MultipleMyelodysplastic SyndromesVasoconstrictor AgentsCushing SyndromeAcute Coronary SyndromePolycystic Ovary SyndromeReflex, PupillaryWilliams SyndromeDiGeorge SyndromeHorner SyndromePrader-Willi SyndromeLong QT SyndromeBronchoconstrictionAmniotic Band SyndromePupilGuillain-Barre SyndromeHemolytic-Uremic SyndromeCompartment SyndromesTourette SyndromeVasodilationAntiphospholipid SyndromeDisease Models, AnimalPorcine Reproductive and Respiratory SyndromeMutationKlinefelter SyndromeMuscle TonusMuscle, Smooth, VascularCarpal Tunnel SyndromePericarditis, ConstrictiveCardiomegalyWerner SyndromeReye SyndromeBlood PressureBartter SyndromeDogsPorcine respiratory and reproductive syndrome virusRats, Sprague-DawleyHELLP SyndromePia MaterTime FactorsBloom SyndromePressureBrugada SyndromeEhlers-Danlos SyndromePedigreeCerebral ArteriesRespiratory Distress Syndrome, AdultAngelman SyndromeVascular ResistanceMesenteric ArteriesHyperesthesiaPhenotypeArteriesVasomotor SystemSevere Acute Respiratory SyndromePhenylephrineMicrocirculationRestless Legs Syndrome15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidDose-Response Relationship, DrugJob SyndromeWiskott-Aldrich SyndromeCoronary VesselsSciatic NeuropathyParaneoplastic SyndromesSweet SyndromeNorepinephrineActomyosinNeuralgiaAcquired Immunodeficiency SyndromeIntellectual DisabilityChurg-Strauss SyndromeSturge-Weber SyndromeEndothelium, VascularBudd-Chiari SyndromeRegional Blood FlowChediak-Higashi SyndromePregnancyEndothelin-1Infant, NewbornCytokinesisTreatment OutcomeWolff-Parkinson-White SyndromeFaciesNitric OxideKallmann SyndromeVasodilator AgentsPotassium ChlorideRats, Wistar